LOX12抗体;LOX12 Antibody—艾普蒂 新品

+ +

•  

   

     Western blot analysis of LOX12 expression in A431 cell lysate.    

  
  

**Background of LOX12 Antibody**

The LOX12 antibody is a tool designed to target 12/15-lipoxygenase (12/15-LOX), an enzyme involved in oxidizing polyunsaturated fatty acids, particularly arachidonic acid, to produce bioactive lipid mediators like 12-HETE and 15-HETE. These metabolites play roles in inflammatory signaling, oxidative stress, and cellular homeostasis. The 12/15-LOX pathway is implicated in various pathological conditions, including atherosclerosis, neurodegenerative diseases (e.g., Alzheimer’s), and diabetic complications, where it contributes to tissue damage through pro-inflammatory and pro-oxidant mechanisms.

LOX12 antibodies are widely used in research to detect 12/15-LOX expression and localization in tissues or cells, employing techniques such as Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). They help elucidate the enzyme’s role in disease models, such as promoting foam cell formation in atherosclerotic plaques or mediating neuronal oxidative damage. Species reactivity typically includes human, mouse, and rat variants, given the enzyme’s conservation.

Recent studies highlight 12/15-LOX as a potential therapeutic target, driving interest in LOX12 antibodies for validating enzyme inhibition or genetic knockdown in preclinical studies. However, challenges remain in distinguishing its activity from related lipoxygenases (e.g., 5-LOX) due to structural similarities. Overall, LOX12 antibodies serve as critical reagents for advancing understanding of lipid-mediated pathologies and exploring targeted interventions.